PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
16-Jul-2024 CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays CD BioSciences
16-Jul-2024 STEMart Announces Transportation and Distribution Simulation Services for Medical Device Manufacturers STEMart
16-Jul-2024 CD Bioparticles Announces Advanced Capabilities in Customized Liposomes for Targeted Delivery CD Bioparticles
16-Jul-2024 CD Bioparticles Simplifies Multi-Analyte Detection with Advanced Multiplex Particles CD Bioparticles
16-Jul-2024 Creative Diagnostics Introduces Patulin Test Reagents for Food Safety Applications Creative Diagnostics
16-Jul-2024 Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development Creative Diagnostics
16-Jul-2024 Creative Diagnostics Launches Reliable Hemagglutination Assay for Virus and Antibody Detection Creative Diagnostics
15-Jul-2024 Integrated DNA Technologies Announces New Licensing Agreement with SeQure Dx to Advance CRISPR-based Therapeutics Integrated DNA Technologies
15-Jul-2024 ViiV Healthcare to announce data from largest head-to-head randomised clinical trial for 2-drug regimen Dovato against 3-drug regimen Biktarvy at AIDS 2024 ViiV Healthcare
13-Jul-2024 GDP Training Course is Now Ready and Free Pharma Lessons
12-Jul-2024 Clinion Wins The Technology Innovation Leadership Award by Frost & Sullivan Clinion Inc
11-Jul-2024 Socioeconomic status significantly affects fertility treatment outcomes, new study shows European Society of Human Reproduction and Embryology
11-Jul-2024 Familial endocrine diseases linked to increased risk of pregnancy loss, new research shows European Society of Human Reproduction and Embryology (ESHRE)
11-Jul-2024 Envirotainer invests in new testing chambers to drive innovation Envirotainer
11-Jul-2024 Quell Therapeutics Appoints Experienced Biopharma Leader Luke Beshar as Independent Chair of its Board of Directors Quell Therapeutics
11-Jul-2024 NICE recommends Ebglyss (lebrikizumab) for use in moderate to severe Atopic Dermatitis in the NHS England in eligible adolescents and adults Almirall
11-Jul-2024 Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart for Atopic Dermatitis Q32 Bio Inc
11-Jul-2024 validation of its AAA EndoStapling solution Aortoseal Endoron Medical
11-Jul-2024 Simris Biologics enters into a collaboration agreement with New Zealand Universities to develop peptide drug conjugates (PDC) Simris Group AB
11-Jul-2024 Cambridge Cognition secures Innovate UK grant for Bio-Hermes 2 project Cambridge Cognition Holdings plc